Patents by Inventor Helena COWLEY

Helena COWLEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • High efficiency oxalate-degrading enzymes for degradation of insoluble and soluble oxalate
    Patent number: 11603524
    Abstract: Disclosed herein are oxalate inducing enzymes with pH and thermal stability and methods of using for oxalate related conditions for in food processing.
    Type: Grant
    Filed: April 4, 2016
    Date of Patent: March 14, 2023
    Assignee: Oxidien Pharmaceuticals, LLC
    Inventors: Aaron B. Cowley, Helena Cowley, Qin Yan, Qingshan Li
  • HIGH EFFICIENCY OXALATE-DEGRADING ENZYMES FOR DEGRADATION OF INSOLUBLE AND SOLUBLE OXALATE
    Publication number: 20220298497
    Abstract: Disclosed herein are oxalate inducing enzymes with pH and thermal stability and methods of using for treatment of oxalate related conditions for in food processing.
    Type: Application
    Filed: March 30, 2022
    Publication date: September 22, 2022
    Inventors: Aaron B. COWLEY, Helena COWLEY, Qin YAN, Qingshan LI
  • SECRETAGOGUES DERIVED FROM OXALOBACTER FORMIGENES
    Publication number: 20220098247
    Abstract: The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or oxalate related imbalance in a subject, wherein the administration of the secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. The invention further relates to a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate related disease, and to a method for preparing a secretagogue.
    Type: Application
    Filed: April 26, 2021
    Publication date: March 31, 2022
    Applicant: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth LINDNER, Helena COWLEY, Aaron COWLEY, Maria ÅKERMAN
  • Secretagogues derived from oxalobacter formigenes
    Patent number: 10988510
    Abstract: The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or oxalate related imbalance in a subject, wherein the administration of the secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. The invention further relates to a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate related disease, and to a method for preparing a secretagogue.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: April 27, 2021
    Assignee: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth Lindner, Helena Cowley, Aaron Cowley, Maria Åkerman
  • SECRETAGOGUES DERIVED FROM OXALOBACTER FORMIGENES
    Publication number: 20190085035
    Abstract: The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or oxalate related imbalance in a subject, wherein the administration of the secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. The invention further relates to a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate related disease, and to a method for preparing a secretagogue.
    Type: Application
    Filed: September 27, 2018
    Publication date: March 21, 2019
    Applicant: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth Lindner, Helena Cowley, Aaron Cowley, Maria Åkerman
  • HIGH EFFICIENCY OXALATE-DEGRADING ENZYMES FOR DEGRADATION OF INSOLUBLE AND SOLUBLE OXALATE
    Publication number: 20180362955
    Abstract: Disclosed herein are oxalate inducing enzymes with pH and thermal stability and methods of using for oxalate related conditions for in food processing.
    Type: Application
    Filed: April 4, 2016
    Publication date: December 20, 2018
    Inventors: Aaron B. COWLEY, Helena COWLEY, Qin YAN, Qingshan LI
  • Secretagogues derived from oxalobacter formigenes
    Patent number: 10125176
    Abstract: The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or oxalate related imbalance in a subject, wherein the administration of the secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. The invention further relates to a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate related disease, and to a method for preparing a secretagogue.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: November 13, 2018
    Assignee: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth Lindner, Helena Cowley, Aaron Cowley, Maria Akerman
  • SECRETAGOGUES DERIVED FROM OXALOBACTER FORMIGENES
    Publication number: 20160137701
    Abstract: The present invention relates to a secretagogue compound derived from oxalate degrading bacteria, for use in the treatment of an oxalate related disease and/or oxalate related imbalance in a subject, wherein the administration of the secretagogue results in a reduction of urinary oxalate and/or plasma oxalate in the subject. The invention further relates to a pharmaceutical composition comprising such a secretagogue compound, a method for treating a subject suffering from an oxalate related disease, and to a method for preparing a secretagogue.
    Type: Application
    Filed: July 3, 2014
    Publication date: May 19, 2016
    Applicant: OXTHERA INTELLECTUAL PROPERTY AB
    Inventors: Elisabeth LINDNER, Helena COWLEY, Aaron COWLEY